National Drug Code (NDC) Database
Bausch Health Companies Inc.
-
NDC:
62660-150
-
Nonproprietary Name:
Rifaximin
-
Dosage Form:
TABLET, COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
550 mg/1
-
Substance:
RIFAXIMIN
-
Start Marketing Date:
2010-05-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bausch Health Ireland Limited
-
NDC:
71071-001
-
Nonproprietary Name:
fluocinolone acetonide implant
-
Dosage Form:
IMPLANT
-
Product Type:
BULK INGREDIENT
-
Strength:
0.59 mg/.59mg
-
Substance:
FLUOCINOLONE ACETONIDE
-
Start Marketing Date:
2008-08-08
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bayer de Mexico, S.A. de C.V.
-
NDC:
12875-9951
-
Nonproprietary Name:
Testosterone Enanthate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
TESTOSTERONE ENANTHATE
-
Start Marketing Date:
2014-04-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CIII
-
Certified Through:
2027-12-31
Bayer HealthCare LLC
-
NDC:
0280-1199
-
Nonproprietary Name:
Dextromethorphan Hydrobromide, Paracetamol, Phenylephrine Hydrochloride
-
Dosage Form:
CAPSULE, LIQUID FILLED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
325; 10; 5 mg/1; mg/1; mg/1
-
Substance:
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
-
Start Marketing Date:
2017-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bayer HealthCare LLC.
-
NDC:
11523-8258
-
Nonproprietary Name:
docusate sodium
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
100 mg/1
-
Substance:
DOCUSATE SODIUM
-
Start Marketing Date:
2025-12-15
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Bayer Healthcare Manufacturing Srl
-
NDC:
23070-8513
-
Nonproprietary Name:
Ciprofloxacin
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
500 mg/1
-
Substance:
CIPROFLOXACIN
-
Start Marketing Date:
2024-07-09
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bayer HealthCare Pharmaceuticals Inc.
-
NDC:
50419-542
-
Nonproprietary Name:
Finerenone
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
40 mg/1
-
Substance:
FINERENONE
-
Start Marketing Date:
2025-07-13
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bayer Hispania, S.L.
-
NDC:
53599-128
-
Nonproprietary Name:
ASPIRIN
-
Dosage Form:
CRYSTAL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
ASPIRIN
-
Start Marketing Date:
1989-02-08
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
35207-0015
-
Nonproprietary Name:
Tetracosactide
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
COSYNTROPIN
-
Start Marketing Date:
2026-06-15
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Create a New Buying Request
Fields marked with * are mandatory.